中国实用儿科杂志 ›› 2024, Vol. 39 ›› Issue (6): 432-438.DOI: 10.19538/j.ek2024060606

• 专题笔谈 • 上一篇    下一篇

炎症小体相关自身炎症性疾病研究进展

  

  1. 重庆医科大学附属儿童医院风湿免疫科  国家儿童健康与疾病临床医学研究中心  儿童发育疾病研究教育部重点实验室  儿童感染与免疫罕见病重庆市重点实验室,重庆  400014
  • 出版日期:2024-06-06 发布日期:2024-07-11
  • 通讯作者: 唐雪梅,电子信箱:tangxuemei2008@163.com
  • 基金资助:
    国家重点研发计划(2021YFC2702003);重庆市教委科学技术研究项目(KJQN202200418);国家儿童健康与疾病临床医学研究中心临床医学研究一般项目(NCRCCHD-2022-YP-07)

Research progress of inflammasome-associated autoinflammatory diseases

  1. Department of Rheumatology,Immunology and Allergy,the Children's Hospital of Chongqing Medical University;National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Development and Disorders;Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity,Chongqing 400014,China
  • Online:2024-06-06 Published:2024-07-11

摘要: 炎症小体是细胞内一种大分子多蛋白复合物, 通过激活调节半胱氨酸天冬氨酸特异蛋白酶-1(caspase-1,CASP1)的活化, 促进白介素(IL)-1β、 IL-18 分泌,引起机体炎症反应。近年来,对不同炎症小体的分子组成和激活机制进行了广泛研究,已对多种炎症小体进行了分子表征,其中4种炎症小体的自激活突变可导致人类单基因自身炎症性疾病。文章主要对NLRP1、CARD8、NLRP3、NLRC4 和Pyrin炎症小体相关自身炎症性疾病的致病机制及临床表现、治疗研究进展进行综述。

关键词: 自身炎症性疾病, 炎症小体, 炎症小体病

Abstract: The inflammasome is a macromolecular multi-protein complex in cells, and its activation can regulate the activation of cysteine aspartic protease-1 (CASP1), promote the activation and secretion of IL-1β and IL-18, and cause inflammation in the body. In recent years, researchers have conducted extensive studies on the molecular composition and activation mechanisms of different inflammasomes, and a variety of inflammasome molecules have been characterized, among which the self-activating mutations of four inflamm-asome can lead to single-gene autoinflammatory diseases in humans. This review focuses on the research progress of the pathogenesis, clinical manifestations and treatment of NLRP1, CARD8, NLRP3, NLRC4 and Pyrin inflammasome-related autoinflammatory diseases.

Key words: autoinflammatory diseases, inflammasome, infla-mmasomapathies